Human CD56bright NK Cells: An Update (Q38781384)

6 September 2017

Human CD56bright NK Cells: An Update (English)

1 reference

6 September 2017

Tatiana Michel

1

1 reference

6 September 2017

Aurélie Poli

2

1 reference

6 September 2017

Angelica Cuapio

3

1 reference

6 September 2017

Benjamin Briquemont

4

1 reference

6 September 2017

Gilles Iserentant

5

1 reference

6 September 2017

Markus Ollert

6

1 reference

6 September 2017

Jacques Zimmer

7

1 reference

6 September 2017

language of work or name

English

0 references

publication date

1 April 2016

1 reference

6 September 2017

Journal of Immunology

1 reference

6 September 2017

196

1 reference

6 September 2017

7

1 reference

6 September 2017

2923-2931

1 reference

CD56bright natural killer (NK) cells: an important NK cell subset.

6 September 2017

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Human natural killer cell development in secondary lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Human Cytokine-Induced Memory-Like Natural Killer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Development, differentiation, and diversity of innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

The biology of innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Natural killer-cell differentiation by myeloid progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Delineation of Natural Killer Cell Differentiation from Myeloid Progenitors in Human

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Practical NK cell phenotyping and variability in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Expansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

The pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

The role of Natural Killer cells in the pathogenesis of rheumatoid arthritis: major contributors or essential homeostatic modulators?

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Emerging role for NK cells in the pathogenesis of inflammatory arthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Homing receptor expression is deviated on CD56+ blood lymphocytes during pregnancy in Type 1 diabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Circulating CD56+ cells of diabetic women show deviated homing potential for specific tissues during and following pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Longitudinal peripheral blood lymphocyte subsets correlate with decreased disease activity in juvenile dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Intrathecal effects of daclizumab treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Diversification and Functional Specialization of Human NK Cell Subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Characterization of tumor infiltrating natural killer cell subset

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Differential upregulation of chemokine receptors on CD56 NK cells and their transmigration to the site of infection in tuberculous pleurisy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

NK cells in central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Therapeutic Advances and Treatment Options in Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

High number of CD56(bright) NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Toll-like receptors expression and interferon-γ production by NK cells in human sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Invasive Surgery Impairs the Regulatory Function of Human CD56 bright Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Natural killer cells and their receptors in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502570

21 January 2018

Identifiers

DOI

10.4049/JIMMUNOL.1502570

1 reference

6 September 2017

1 reference